Health & Life Sciences jobs in the UK
30 venture-backed startups tracked every morning.
183 roles are open at 26 health & life sciences startups. That is 5 more (3.1%) than on 4 October.
Steady. Health & Life Sciences posted 11% of new startup roles in the last four weeks and holds 8% of open ones.
Hiring momentum
Roles added and taken down each week, ignoring reposts.
AddedTaken down
Who is driving it
Change in open roles since 4 October.
- Flo HealthDigital health and care, 33 open+8
- NumanDigital health and care, 16 open+3
- LimbicDigital health and care, 7 open+3
- AccurxDigital health and care, 13 open−7
- Constructive BioBiotech and drug discovery, 2 open−2
- Latent LabsBiotech and drug discovery, 7 open−2
Inside health & life sciences
- Digital health and care01Health, Accurx, Doccla, Evaro, Flo Health, Limbic, Numan, Semble, SheMed, Simple99+9%
- Biotech and drug discoveryAlchemab Therapeutics, Antiverse, Automata, Basecamp Research, Cellular Origins, Constructive Bio, Engitix, Healx, IMU Biosciences, Latent Labs, Lindus Health, OMass Therapeutics48+4%
- Medtech and diagnosticsCoMind, Qureight, Scarlet, Skin Analytics36−22%
What it hires for
32% of roles posted in the last four weeks were engineering and data, against 33% of what is open. Sales and customer roles: 23%, against 27%.
- Open roles today
- Posted in the last 4 weeks
- Engineering and data
- Sales and customers
- Science and hardware
- Operations and support
- Product and design
Before you apply
Typical open role
Half of open roles have been up for longer. Across all startups it is 47 days.
Open for 90 days or more
39 of 183 roles. Some are hard to fill, some may already be filled.
In London
15% are elsewhere in the UK and 31% abroad.
List a salary
Across all startups it is 14%.
Raised in the last six months
Money in, and how many roles each has open today.
- ScarletSeries B, October 2026, $50M19 open
- OMass TherapeuticsSeries C, October 2026, $310M (£233.8m)1 open
- Sensible BiotechnologiesSeries A, October 2026, $47M (incl. up to $20m non-dilutive)not tracked yet
- adsilicoSeries A, October 2026, £10mnot tracked yet
- SavaSeries B, October 2026, €32.1mnot tracked yet
- MicrobioticaSeries C, October 2026, £36m (first close)not tracked yet
- Basecamp ResearchSeries C, September 2026, $140m13 open
- QureightSeries B, July 2026, £15m ($20m)4 open
- Alchemab TherapeuticsSeries A, July 2026, £25m (~$34m)1 open
- TidalSenseSeries B, July 2026, £14.2m ($19m)0 open
In the news
The last three weeks, from trusted publishers only.
Latest health & life sciences roles
Search all 183- £110k–£140kYesterdayApply
- £150k–£190kYesterdayApply
- £60k–£70kYesterdayApply
- Freelance Performance Copywriter (3 months, full time)
Flo Health, United Kingdom
Licensed to sponsor visas
Salary not listedYesterdayApply - Salary not listedYesterdayApply
- Salary not listedYesterdayApply
Change compares the same companies on 4 October and 1 November. Companies whose job boards we can't read yet are left out.